Expertise
Whether you are a researcher from a small lab or an engineer running massive operations, our tools, services and digital platforms empower you to work more effectively - from discovery to commercialization. Our business include:
Select your Market
Our customers from academia, pharma and biotech around the world rely on our tools, services and expertise to do their best science. We offer them one of the broadest portfolios in the industry. Plus, our presence extends well beyond labs: our innovations touch individuals around the world.
Explore Our OfferingsWhether you are a researcher from a small lab or an engineer running massive operations, our tools, services and digital platforms empower you to work more effectively - from discovery to commercialization. Our business include:
50+
Manufacturing and Testing Sites
60+
Distribution Centers
26K+
Employees
300K+
Products
Proposed acquisition would strengthen company’s quality-control workflow offering with Rapid Micro Biosystems’ Growth Direct® automated microbial quality-control platform
Performance was driven by Process Solutions, Rare Diseases and Semiconductor Solutions, in line with the company’s focus on high growth value drivers.
EMD Serono announced today that the U.S. FDA has approved PIMJETMI (pimicotinib) as a systemic treatment for patients with symptomatic TGCT.
The company has signed a definitive agreement to divest its contract development and manufacturing organization (CDMO) business to Lonza.